20 years of the Mexican Health and Aging Study
Salud Pública de México · 2023-09-15 · 65 (5, sept-oct) · 423-424
DOI: 10.21149/15311 ↗At a glance
Journal article in Salud Pública de México, published online on 2023-09-15. Written by Rebeca Wong and 4 co-authors. Institution: University of Texas Medical Branch. Texas, United States.. rewong@utmb.edu. Major MEDLINE topics: Aging, Independent Living. Cited 12 times so far (Crossref). The full text is freely available (open access, CC BY-NC-SA 4.0).
Abstract (original language)
The Mexican Health and Aging Study (MHAS) is a longitudinal study using a national sample of approximately 15,000 community-dwelling adults aged 50 years old and older in Mexico. Spanning over 20 years (2001-2021), six waves of data collection establish the MHAS as the leading data platform for the study of aging in Latin America.
Subjects
MeSH terms (MEDLINE)
Authors and institutions
- University of Texas Medical Branch. Texas, United States.. rewong@utmb.edu.
- Instituto Nacional de Geriatría. Mexico.. mcgarcia@inger.gob.mx.
- University of Texas Medical Branch. Texas, United States.. lmgutierrez@inger.gob.mx.
- University of Southern California. United States.. eaguilav@usc.edu.
- UTHealth Houston. United States.. rasamper@utmb.edu.
Cite
APA
Wong, R., García-Peña, C., Gutiérrez-Robledo, L. M., Aguila, E., & Samper-Ternent, R. (2023). 20 years of the Mexican Health and Aging Study. Salud Pública de México, 65(5, sept-oct), 423-424. https://doi.org/10.21149/15311
Vancouver
Wong R, García-Peña C, Gutiérrez-Robledo LM, Aguila E, Samper-Ternent R. 20 years of the Mexican Health and Aging Study. Salud Pública de México. 2023;65(5, sept-oct):423-424. doi:10.21149/15311
BibTeX
@article{Wong2023,
author = {Wong, Rebeca and García-Peña, Carmen and Gutiérrez-Robledo, Luis Miguel and Aguila, Emma and Samper-Ternent, Rafael},
title = {20 years of the Mexican Health and Aging Study},
journal = {Salud Pública de México},
year = {2023},
volume = {65},
number = {5, sept-oct},
pages = {423--424},
doi = {10.21149/15311}
}
EUVIMED